Philippe Archinard

Philippe Archinard began his professional career in 1985 with bioMérieux, where he held various positions in France and the United States, including CEO of U.S. operations.

He served as Chief Executive Officer of Innogenetics from March 2000 until his appointment as CEO of Transgene. He holds a chemical engineering degree and a Ph.D. in biochemistry from Lyon University, and completed the PMD program at Harvard Business School.